Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changed from v3.5.3 to v3.5.4, signaling an update to the page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a new build of the page. The update appears in the page footer as the current revision.SummaryDifference0.0%

- Check23 days agoChange DetectedThe record history reflects recent updates to Study Status and Contacts/Locations for the study, along with a new version submitted on 2026-04-17. One earlier version entry (2026-04-02) was removed from the history list.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check38 days agoChange DetectedThe record now shows updated Contacts/Locations and Study Status sections (version 77), reflecting current trial contacts and recruitment status.SummaryDifference0.2%

- Check45 days agoChange DetectedAdded Contacts/Locations and Study Status sections to the record (update on 2026-03-31; version 76), replacing the previous 2026-03-16 entry.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.